3-Deoxy-3-acetyl abiraterone-3-ene

An impurity of Abiraterone. Abiraterone acetate is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga.
Supplier BOC Sciences
Product # B0038-007224
Pricing 10 mg/unit USD $1099
Molecular Weight 373.54
Molecular Formula C26H31NO
Feedback